Yahoo! Inc. (NASDAQ:YHOO) was downgraded by equities research analysts at Vetr from a “buy” rating to a “hold” rating in a report released on Thursday. They presently have a $37.11 target price on the digital content provider’s stock. Vetr‘s price objective would suggest a potential upside of 0.95% from the company’s previous close.

In other Yahoo! news, CRO Lisa Utzschneider sold 820 shares of the company’s stock in a transaction on Friday, May 20th. The shares were sold at an average price of $36.04, for a total transaction of $29,552.80. Following the transaction, the executive now owns 630,643 shares in the company, valued at $22,728,373.72. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Kenneth A. Goldman sold 200,000 shares of the company’s stock in a transaction on Tuesday, May 3rd. The stock was sold at an average price of $36.10, for a total transaction of $7,220,000.00. Following the transaction, the chief financial officer now owns 853,811 shares in the company, valued at approximately $30,822,577.10. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors have added to or reduced their stakes in YHOO. NN Investment Partners Holdings N.V. acquired a new position in Yahoo! during the first quarter valued at $206,000. IFP Advisors Inc increased its position in Yahoo! by 7.4% in the first quarter. IFP Advisors Inc now owns 8,518 shares of the digital content provider’s stock valued at $314,000 after buying an additional 587 shares during the last quarter. Reynolds Capital Management LLC acquired a new position in Yahoo! during the first quarter valued at $368,000. E&G Advisors LP increased its position in Yahoo! by 9.5% in the fourth quarter. E&G Advisors LP now owns 10,350 shares of the digital content provider’s stock valued at $344,000 after buying an additional 900 shares during the last quarter. Finally, Howard Hughes Medical Institute increased its position in Yahoo! by 6.1% in the first quarter. Howard Hughes Medical Institute now owns 13,294 shares of the digital content provider’s stock valued at $489,000 after buying an additional 766 shares during the last quarter.

Several other research firms have also weighed in on YHOO. Evercore ISI reiterated a “hold” rating and issued a $37.00 target price on shares of Yahoo! in a report on Thursday, April 21st. Needham & Company LLC restated a “buy” rating and set a $40.00 price objective on shares of Yahoo! in a report on Thursday, April 21st. Jefferies Group restated a “buy” rating and set a $43.00 price objective (up from $40.00) on shares of Yahoo! in a report on Thursday, April 21st. Pacific Crest restated an “equal weight” rating on shares of Yahoo! in a report on Thursday, April 21st. Finally, B. Riley restated a “neutral” rating and set a $38.00 price objective on shares of Yahoo! in a report on Friday, April 22nd. One analyst has rated the stock with a sell rating, twenty have assigned a hold rating and twenty-three have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $41.92.

Yahoo! (NASDAQ:YHOO) traded up 3.29% during midday trading on Thursday, hitting $36.76. The company had a trading volume of 16,285,747 shares. The firm’s market cap is $34.89 billion. The stock has a 50 day moving average of $36.86 and a 200 day moving average of $33.53. Yahoo! has a 52-week low of $26.15 and a 52-week high of $43.78.

Yahoo! Inc is a technology company. The Company is engaged in providing Internet search, communication and digital content. The Company manages its business geographically: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. The Company’s products include Search, Communications, Digital content, Flickr, and Tumblr.

To view Vetr’s full report, visit Vetr’s official website.